On ECHEMI
Home > Drugs > leukemia
leukemia
Leukemia was first identified by German pathologist Rudolf Virchow in 1847. The cause of leukemia is the abnormal functioning of the hematopoietic tissue in the bone marrow due to mutations in the DNA in the cells. Stem cells in the bone marrow can produce thousands of red and white blood cells every day. Leukemia patients overproduce immature white blood cells, which interferes with other work of the bone marrow, which reduces the bone marrow's ability to produce other blood cells. Leukemia can spread to the lymph nodes, spleen, liver, central nervous system and other organs.
Related Drugs
Ifosfamide
Indication: 1. This product has a wide anti-tumor spectrum and is mainly suitable for soft tissue tumors, testicular tumors, malignant lymphomas, lung cancer, breast cancer, ovarian cancer, cervical cancer and childhood tumors; 2. Used for anti-tumor: leukemia, spermatogonial testicular cancer, lung cancer, non-Hodgkin's lymphoma, cervical cancer, ovarian cancer and recurrent and refractory solid tumors.
Ifosfamide
Indication: 1. This product has a wide anti-tumor spectrum and is mainly suitable for soft tissue tumors, testicular tumors, malignant lymphomas, lung cancer, breast cancer, ovarian cancer, cervical cancer and childhood tumors; 2. Used for anti-tumor: leukemia, spermatogonial testicular cancer, lung cancer, non-Hodgkin's lymphoma, cervical cancer, ovarian cancer and recurrent and refractory solid tumors.
Manufacturer:

Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical Co., Ltd.

Ifosfamide
Indication: 1. This product has a wide anti-tumor spectrum and is mainly suitable for soft tissue tumors, testicular tumors, malignant lymphomas, lung cancer, breast cancer, ovarian cancer, cervical cancer and childhood tumors; 2. Used for anti-tumor: leukemia, spermatogonial testicular cancer, lung cancer, non-Hodgkin's lymphoma, cervical cancer, ovarian cancer and recurrent and refractory solid tumors.
Manufacturer:

Guangdong Lingnan Pharmaceutical Co., Ltd.

Ifosfamide
Indication: 1. This product has a wide anti-tumor spectrum and is mainly suitable for soft tissue tumors, testicular tumors, malignant lymphomas, lung cancer, breast cancer, ovarian cancer, cervical cancer and childhood tumors; 2. Used for anti-tumor: leukemia, spermatogonial testicular cancer, lung cancer, non-Hodgkin's lymphoma, cervical cancer, ovarian cancer and recurrent and refractory solid tumors.
Recombinant human interferon α2b for injection
Indication: It can be used to treat acute and chronic viral hepatitis (type B, type C, etc.), genital warts, hairy cell leukemia, chronic myeloid leukemia, lymphoma, AIDS-related Kaposi's sarcoma, malignant melanoma and other diseases.
Manufacturer:

Anhui Anke Biotechnology (Group) Co., Ltd.

Recombinant human interferon α2b for injection
Indication: 1. Used to treat certain viral diseases, such as acute and chronic viral hepatitis, herpes zoster, and genital warts. 2. Used to treat certain tumors, such as hairy cell leukemia, chronic myeloid leukemia, multiple myeloma, non-Hodgkin's lymphoma, malignant melanoma, renal cell carcinoma, laryngeal papilloma, Kaposi's sarcoma, ovarian cancer, basal cell carcinoma, bladder cancer, etc.
Manufacturer:

Zhejiang Beisheng Pharmaceutical Hansheng Pharmaceutical Co., Ltd.

Recombinant human interferon α2b for injection
Indication: This product is suitable for the treatment of viral diseases and certain malignant tumors. It has been approved for the treatment of chronic hepatitis B, hepatitis C and hairy cell leukemia. Clinical trial results and literature reports have shown that it is effective in treating viral diseases such as herpes zoster, condyloma acuminatum, epidemic hemorrhagic fever and respiratory syncytial virus pneumonia in children. It can be used to treat malignant tumors such as chronic myeloid leukemia, melanoma, lymphoma, etc.
Manufacturer:

Anhui Anke Biotechnology (Group) Co., Ltd.

Recombinant human interferon α2b for injection
Indication: This product is suitable for the treatment of viral diseases and certain malignant tumors. It has been approved for the treatment of chronic hepatitis B, hepatitis C and hairy cell leukemia. Clinical trial results and literature reports have shown that it is effective in treating viral diseases such as herpes zoster, condyloma acuminatum, epidemic hemorrhagic fever and respiratory syncytial virus pneumonia in children. It can be used to treat malignant tumors such as chronic myeloid leukemia, melanoma, lymphoma, etc.
Manufacturer:

Anhui Anke Biotechnology (Group) Co., Ltd.

Recombinant human interferon α2b for injection
Indication: It can be used to treat acute and chronic viral hepatitis (type B, type C, etc.), genital warts, hairy cell leukemia, chronic myeloid leukemia, lymphoma, AIDS-related Kaposi's sarcoma, malignant melanoma and other diseases.
Manufacturer:

Beijing Yuance Pharmaceutical Co., Ltd.

Hydroxyurea tablets
Indication: It has a positive effect on both intractable psoriasis and pustular psoriasis, and can reduce the pus scars, fever and poisoning symptoms of systemic pustular psoriasis. For short-term use, its toxicity is less than that of methotrexate. It seems that this product is suitable for patients with severe psoriasis who have liver damage and are not suitable for methotrexate or who are ineffective with methotrexate.
Manufacturer:

Beijing Jialin Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.